Investment Management Corp of Ontario (IMCO)’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $947K | Sell |
7,531
-400
| -5% | -$50.3K | 0.01% | 426 |
|
|
2025
Q1 | $877K | Buy |
7,931
+3,341
| +73% | +$370K | 0.02% | 429 |
|
|
2024
Q4 | $627K | Sell |
4,590
-188
| -4% | -$25.7K | 0.02% | 271 |
|
|
2024
Q3 | $551K | Buy |
4,778
+1,200
| +34% | +$138K | 0.01% | 520 |
|
|
2024
Q2 | $493K | Buy |
3,578
+600
| +20% | +$82.6K | 0.01% | 451 |
|
|
2024
Q1 | $411K | Sell |
2,978
-700
| -19% | -$96.5K | 0.01% | 447 |
|
|
2023
Q4 | $485K | Buy |
+3,678
| New | +$485K | 0.01% | 471 |
|
|
2023
Q1 | – | Sell |
-9,361
| Closed | -$1.12M | – | 202 |
|
|
2022
Q4 | $1.12M | Buy |
+9,361
| New | +$1.12M | 0.05% | 140 |
|